Trending...
- California: Governor Newsom signs new law to protect workers, require disclosures on AI-generated advertising - 145
- California: Governor Newsom signs legislation 9.14.2026 - 133
- California: Governor Newsom expands film and TV tax credits with new legislation, creates tax credit to support post-production jobs
IRVINE, Calif.--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today announced that in the last twelve months, the United States Patent and Trademark Office has granted eight patents and allowed four patent applications related to the company's sacral neuromodulation technology.
The patents and allowed applications are part of Axonics' patent portfolio and represents technology internally developed by the company covering a range of subject matter that includes the Axonics external trial system, tined lead, implantable neurostimulator, clinician programmer, wireless charging system and patient remote control.
The granted U.S. patents are numbered: 11,083,903; 11,110,283; 11,116,985; 11,123,569; 11,213,675; 11,260,236; 11,389,659; and D952,859. The allowed U.S. patent applications are numbered: 16/547,324; 16/871,738; 16/913,532; and 16/882,295.
"Axonics is committed to developing best-in-class technology to serve the unmet needs of the millions of adults suffering from incontinence. The volume, subject matter diversity, and breadth of these patents demonstrate the investment in innovation that Axonics continues to make in sacral neuromodulation technology," said Raymond W. Cohen, chief executive officer.
More on The Californer
About Axonics
Based in Irvine, Calif., Axonics is a global medical technology company that is developing and commercializing novel products for adults with bladder and bowel dysfunction. Axonics recently ranked No. 1 on the 2021 Deloitte Technology Fast 500™ and the 2022 Financial Times ranking of the 500 fastest growing companies in the Americas.
Axonics sacral neuromodulation (SNM) systems provide adults suffering from overactive bladder and/or fecal incontinence with long-lived, easy to use, safe, clinically effective therapy. In addition, the company's best-in-class urethral bulking hydrogel, Bulkamid®, provides safe and durable symptom relief to women with stress urinary incontinence (SUI). Overactive bladder affects an estimated 87 million adults in the U.S. and Europe, with an additional 40 million adults estimated to suffer from fecal incontinence. SUI affects an estimated 29 million women in the U.S. alone. Axonics' clinically proven products are offered at hundreds of medical centers across the U.S. and abroad. Reimbursement coverage is well established in the U.S. and is a covered service in most European countries. For more information, visit www.axonics.com.
More on The Californer
Contacts
Neil Bhalodkar
949-336-5293
ir@axonics.com
The patents and allowed applications are part of Axonics' patent portfolio and represents technology internally developed by the company covering a range of subject matter that includes the Axonics external trial system, tined lead, implantable neurostimulator, clinician programmer, wireless charging system and patient remote control.
The granted U.S. patents are numbered: 11,083,903; 11,110,283; 11,116,985; 11,123,569; 11,213,675; 11,260,236; 11,389,659; and D952,859. The allowed U.S. patent applications are numbered: 16/547,324; 16/871,738; 16/913,532; and 16/882,295.
"Axonics is committed to developing best-in-class technology to serve the unmet needs of the millions of adults suffering from incontinence. The volume, subject matter diversity, and breadth of these patents demonstrate the investment in innovation that Axonics continues to make in sacral neuromodulation technology," said Raymond W. Cohen, chief executive officer.
More on The Californer
- Best Dodge Lemon Law Attorney in Los Angeles County
- Care En Route Launches Location-Aware Booking For Mobile Healthcare Practices
- What they are saying: California leaders praise Governor Newsom's democracy defending action ahead of November elections
- Governor Newsom signs bill expanding fuel options to help Californians save at the pump, amid Donald Trump's gas price crisis
- Regional Magazines Shine at IRMA Awards
About Axonics
Based in Irvine, Calif., Axonics is a global medical technology company that is developing and commercializing novel products for adults with bladder and bowel dysfunction. Axonics recently ranked No. 1 on the 2021 Deloitte Technology Fast 500™ and the 2022 Financial Times ranking of the 500 fastest growing companies in the Americas.
Axonics sacral neuromodulation (SNM) systems provide adults suffering from overactive bladder and/or fecal incontinence with long-lived, easy to use, safe, clinically effective therapy. In addition, the company's best-in-class urethral bulking hydrogel, Bulkamid®, provides safe and durable symptom relief to women with stress urinary incontinence (SUI). Overactive bladder affects an estimated 87 million adults in the U.S. and Europe, with an additional 40 million adults estimated to suffer from fecal incontinence. SUI affects an estimated 29 million women in the U.S. alone. Axonics' clinically proven products are offered at hundreds of medical centers across the U.S. and abroad. Reimbursement coverage is well established in the U.S. and is a covered service in most European countries. For more information, visit www.axonics.com.
More on The Californer
- Danny's Ice Cream Truck Is Coming Home to San Diego
- A3 Analytics Names Greg Snyder as Co-Founder and Chief Operating Officer
- California: Governor Newsom expands film and TV tax credits with new legislation, creates tax credit to support post-production jobs
- KayeDinero Writes Python. Does That Make Her an AI Artist? "C'mon Nah."
- Governor Newsom signs new laws to protect California elections from Trump interference
Contacts
Neil Bhalodkar
949-336-5293
ir@axonics.com
Filed Under: Business
0 Comments
Latest on The Californer
- Senior Travel Deal Of The Week: 16-Day Morocco Adventure Drops From $4,295 To $995
- Ragin' Cajun Announces New Cheeseburger Seasoning on National Cheeseburger Day
- Warrant Activity, AVERSA™ Progress and a Potentially Transformative Fall Take Center Stage: Nutriband Inc. (N A S D A Q: NTRB)
- California: Governor Newsom issues executive order to accelerate independent oversight and advance the creation of an AI kill switch
- Manuel Jesse Lopez Expands Amazon Influencer Storefront To Global Audience
- xBxBio Opens EU, Asia and Latin America Regulatory Leadership Searches
- TitleChain Foundation Opens Public Commons Reference Project for Real-World Asset Transfer
- Put Your Herd on Your Phone: Kiko Nation Makes Livestock Management Simple
- Chapter Enterprise and NuGuard AI Announce Strategic Partnership to Make Enterprise Agentic AI Both Role-Intelligent and Audit-Ready
- iSmile Orthodontics - San Ramon Trains Its Whole Team on AI, Invites Other Practices to Join
- Future Intelligence Think Tank Surpasses 1,000 Members Exploring Human and Artificial Intelligence
- Manuel Jesse Lopez Launches Official Amazon Influencer Storefront to Streamline Consumer Purchases
- Connect Names Zeb Hastings Head of Partnerships & Growth
- Server Memory Up 27 Percent Since March While DDR4 Falls 25 Percent: eRacks Publishes Its Tracking
- Sons of Morehouse Carry the Light: David Roach and Larry Calhoun Keep Independent Black Stories Alive from Stage to Screen
- Humphrey Jr. Returns Brings a Beloved Northern California Whale Story to a New Generation
- mQOL Announces Jessica Willoughby as Chief Operating Officer
- Wheelchair to Founder: At 70, Jonine Scott Turns a Personal Health Crisis Into Luna Select Market
- California: Governor Newsom announces appointments 9.17.2026
- California: Governor Newsom proclaims Constitution Day and Citizenship Day